Related Experiment Videos
The relation between visual hallucinations and visual evoked potential in Parkinson disease
Hideaki Matsui1, Fukashi Udaka, Akiko Tamura
1Department of Neurology, Sumitomo Hospital, Osaka, Japan. matsui-hideaki@sumitomo-hp.or.jp
Clinical Neuropharmacology
|March 30, 2005
Summary
Visual hallucinations in Parkinson disease are linked to longer visual evoked potential (VEP) latency. This finding suggests VEPs could help predict visual hallucinations in Parkinson disease patients.
Area of Science:
- Neuroscience
- Clinical Neurology
Background:
- Hallucinations are a common and distressing symptom in Parkinson disease (PD).
- The underlying mechanisms of visual hallucinations (VH) in PD remain unclear.
- Visual evoked potentials (VEPs) offer a measurable neurophysiological correlate of visual processing.
Purpose of the Study:
- To investigate the relationship between visual hallucinations and VEPs in Parkinson disease.
- To determine if VEPs can serve as a biomarker for VH in PD.
Main Methods:
- Nineteen Parkinson disease patients were recruited.
- Patients were categorized into two groups: those with visual hallucinations (VH group) and those without (no-VH group).
- VEPs were elicited using a checkerboard stimulus in a drug-free state and analyzed for latency and amplitude.
Main Results:
- Multivariate regression analysis identified average P100 latency as a significant factor.
- Elongated P100 latency in VEPs was significantly associated with the presence of visual hallucinations.
- No significant differences were found in other VEP parameters between the groups.
Conclusions:
- A strong association exists between visual hallucinations and prolonged VEP latency in Parkinson disease.
- VEP latency, specifically P100 latency, shows potential as a predictive biomarker for visual hallucinations in PD.
- Further research is warranted to explore the clinical utility of VEPs in managing PD-related hallucinations.